ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
What’s reshaping nuclear licensing and compliance today?
Mark Reidmeyer
It is the convergence of urgency, innovation, and modernization that is reshaping nuclear licensing and compliance today.
For decades, nuclear licensing operated in a relatively stable environment built around large light water reactors, predictable review cycles, and well-established regulatory pathways. Today, that model is evolving rapidly. Advanced reactors, AI-enabled tools, digital engineering platforms, grid reliability concerns, and aggressive decarbonization goals are all pushing the industry—and regulators—to move faster and think differently.
N. Spronk, R. J. Van Hoek
Nuclear Technology | Volume 14 | Number 1 | April 1972 | Pages 96-104
Technical Paper | Session on Physics of Nuclear Materials Safeguards / Analysis | doi.org/10.13182/NT72-A31103
Articles are hosted by Taylor and Francis Online.
The 64Cu production in biological tissues after reactor neutron activation was compared (a) in different types of tissue and (b) in different sizes of samples. The comparison showed that composition of animal tissue should be taken into account since it is a source of interference during neutron activation of copper. Undirectional deviations of 10% depending on sample type and size can be caused by this interference. The copper content in pooled tissues of Lymnaea stagnalis is an example. If properly corrected, these were 21 µg dry intestinal tissue and 5.7 µg / g shell.